| 2-HG | R(−)-2-hydroyglutarate |
| α-KG | α-ketoglutarate |
| ABL | Abelson tyrosine protein kinase |
| AC | articular cartilage |
| ADIPOR | adiponectin receptor |
| ADSF | adipose tissue-specific secretory factor |
| AKT | v-Akt murine thymoma viral oncogene homolog |
| AMPK | AMP-activated protein kinase |
| AP-1 | activator protein 1 |
| ARF | alternative reading frame |
| ATO | arsenic trioxide |
| BCL-XL | B-cell lymphoma-extra large |
| CCL | C-C motif chemokine ligand |
| CCR | C-C motif chemokine receptor |
| CD | cluster of differentiation |
| CDK4 | cyclin dependent kinase 4 |
| CDKN2A | cyclin dependent kinase inhibitor 2A |
| COL2A1 | collagen type II α 1 chain |
| COX-2 | cyclooxygenase 2 |
| CTGF | connective tissue growth factor |
| CXCL12 | C-X-C motif chemokine ligand 12 |
| CXCR4 | C-X-C motif chemokine receptor 4 |
| DHH | desert hedgehog |
| DDK1 | dickkopf WNT signaling pathway inhibitor 1 |
| ECM | extracellular matrix |
| ERK | extracellular signal-regulated kinase |
| ET-1 | endothelin-1 |
| ETS | avian erythroblastosis virus E26 oncogene homolog |
| FAK | focal adhesion kinase |
| FGF2 | fibroblast growth factor |
| FGFR1 | fibroblast growth factor receptor 1 |
| FZD3 | frizzled-3 |
| GLI | glioma associated oncogene family |
| HDAC6 | histone deacetylase 6 |
| HES1 | hairy and enhancer of split 1 |
| HEY | hairy/enhancer-of-split related with YRPW motif |
| Hh | hedgehog |
| HIF-1α | hypoxia-inducible factor-1α |
| HLA-DR | human leukocyte antigen—antigen D related |
| HSC | hematopoietic stem cells |
| ICAM | intercellular adhesion molecule |
| IDH | isocitrate dehydrogenase |
| IGF | insulin like growth factor |
| IGF1R | insulin like growth factor 1 receptor |
| IHH | indian hedgehog |
| ISCT | International Society for Cellular Therapy |
| JAG1 | jagged 1 |
| JMJC | jumonjiC domain-containing |
| MAPK | mitogen activated protein kinase |
| MCL-1 | myeloid cell leukemia sequence 1 |
| MDM2 | mouse double minute 2 |
| MDR1 | multidrug resistance protein 1 |
| MEK | MAPK/ERK kinase |
| MMP | matrix metalloproteinases |
| MSC | mesenchymal stem cells |
| MSPC | mesenchymal stem and progenitor cells |
| mTOR | mammalian target of rapamycin |
| NADPH | nicotinamide adenine dinucleotide phosphate |
| NF-κB | nuclear factor kappa B |
| NOTCH | notch homolog |
| OA | osteoarthritis |
| OPN | osteopontin |
| p70S6K | p70 S6 kinase |
| PDGFR | platelet derived growth factor receptor |
| PHD | prolyl hydroxylase |
| PI3K | phosphatidylinositol 3-kinase |
| PIIBNP | collagen type IIB splice variant |
| PD-L1 | programmed cell death ligand 1 |
| PGP-1 | phagocytic glycoprotein 1 |
| PTCH1 | patched 1 |
| r | recombinant |
| RANKL | receptor activator of NF-κB ligand |
| RANTES | regulated upon activation, normally T-expressed, and presumably secreted |
| RB | retinoblastoma suspectibility protein |
| RET | rearranged during transfection |
| RGS16 | regulator of G-protein signaling 16 |
| RUNX2 | runt related transcription factor 2 |
| SHH | sonic hedgehog |
| SMO | smoothened |
| SNP | single nucleotide polymorphism |
| SOX | SRY-related HMG box-containing |
| STRO-1 | stromal cell surface marker-1 |
| SZ | superficial zone |
| TIE2 | tyrosine kinase with Ig and EGF homology domains-2 |
| TET | ten-eleven-translocation |
| VEGF | vascular endothelial growth factor |
| VEGFR | vascular endothelial growth factor receptor |
| WHO | World Health Organization |
| WIF1 | WNT inhibitory factor 1 |
| WNT | wingless-type MMTV integration site family |